Apogee Therapeutics Inc (APGE)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current APGE market cap is 1.96B. The company's latest EPS is USD -3.0611 and P/E is -10.83.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -42.6M | -38.18M | -44.12M | -58.69M | -75.88M |
| Net Income | -31.74M | -32.09M | -33.82M | -49.02M | -67.22M |
| Year End December 30 2024 | 2023 | 2024 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -93M | -216.87M |
| Net Income | -83.99M | -182.15M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Assets | 401.4M | 823.66M | 800.66M | 776.29M | 753.95M |
| Total Liabilities | 21.49M | 22.18M | 27.02M | 41.88M | 37.16M |
| Total Equity | 379.91M | 801.48M | 773.64M | 734.4M | 716.79M |
| Year End December 30 2024 | 2023 | 2024 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 401.4M | 753.95M |
| Total Liabilities | 21.49M | 37.16M |
| Total Equity | 379.91M | 716.79M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Operating | -74.76M | -31.64M | -60.94M | -103.46M | -171.17M |
| Investing | -273.91M | -51.74M | -200.45M | -346.83M | -300.46M |
| Financing | 315.39M | 450.52M | 450.37M | 450.75M | 495.11M |
| Year End December 30 2024 | 2023 | 2024 |
|---|---|---|
| USD ($) | USD ($) | |
| Operating | -74.76M | -171.17M |
| Investing | -273.91M | -300.46M |
| Financing | 315.39M | 495.11M |
| Market Cap | 1.96B |
| Price to Earnings Ratio | -10.83 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 13.92 |
| Price to Book Ratio | 2.75 |
| Dividend Yield | - |
| Shares Outstanding | 59.5M |
| Average Volume (1 week) | 697.31k |
| Average Volume (1 Month) | 820.18k |
| 52 Week Change | -35.82% |
| 52 Week High | 63.50 |
| 52 Week Low | 26.20 |
| Spread (Intraday) | 27.15 (51.08%) |
| Company Name | Apogee Therapeutics Inc |
| Address |
1209 orange st wilmington, delaware 19801 |
| Website | https://www.apogeetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
